Published in Infect Immun on June 01, 1992
Production of protective human antipneumococcal antibodies by transgenic mice with human immunoglobulin loci. Infect Immun (2000) 0.97
Abrogation of suppression of delayed hypersensitivity induced by Candida albicans-derived mannan by treatment with monophosphoryl lipid A. Infect Immun (1993) 0.86
Cellular basis of decreased immune responses to pneumococcal vaccines in aged mice. Infect Immun (1996) 0.85
Reversal of age-associated decline in immune response to Pnu-imune vaccine by supplementation with the steroid hormone dehydroepiandrosterone. Infect Immun (1993) 0.79
The pneumococcus: host-organism interactions and their implications for immunotherapy and immunoprophylaxis. Thorax (1994) 0.76
A cell-surface molecule involved in organ-specific homing of lymphocytes. Nature (1983) 8.20
Use of erythrocytes sensitized with purified pneumococcal polysaccharides for the assay of antibody and antibody-producing cells. Appl Microbiol (1969) 5.29
Characterization of the antibody response to type 3 pneumococcal polysaccharide at the cellular level. I. Dose-response studies and the effect of prior immunization on the magnitude of the antibody response. Immunology (1971) 2.74
The half-lives of serum immunoglobulins in adult mice. Eur J Immunol (1988) 2.73
Pneumococcal vaccine efficacy in selected populations in the United States. Ann Intern Med (1986) 2.26
Clinical and epidemiologic studies of pneumococcal infection in children. Pediatr Infect Dis (1986) 2.19
The clinical effectiveness of pneumococcal vaccine in the elderly. Ann Intern Med (1988) 2.17
Origin and differentiation of lymphocytes involved in the secretory IgA responses. Cold Spring Harb Symp Quant Biol (1977) 2.09
The cellular and subcellular bases of immunosenescence. Adv Immunol (1989) 1.59
Splenic dependence of the antibody response to thymus-independent (TI-2) antigens. Eur J Immunol (1985) 1.56
INDUCTION OF UNRESPONSIVENESS AND IMMUNITY IN NEWBORN AND ADULT MICE WITH PNEUMOCOCCAL POLYSACCHARIDE. J Immunol (1963) 1.55
Bacterial pneumonia in the elderly. Medicine (Baltimore) (1983) 1.41
The role of the spleen in resistance to infection. Annu Rev Med (1986) 1.32
Lipid A and immunotherapy. Rev Infect Dis (1984) 1.29
Immune function in aged mice. II. B-cell function. Cell Immunol (1977) 1.20
Modulation of the biological activity of bacterial endotoxin by incorporation into liposomes. J Immunol (1987) 1.11
Induction of B lymphocyte proliferation by monoclonal anti-Lyb 2 antibody. J Immunol (1983) 1.11
Ability of monophosphoryl lipid A to augment the antibody response of young mice. Infect Immun (1988) 1.09
Differential responses of B cells from the spleen and lymph node to TNP-Ficoll. J Immunol (1988) 1.07
Synthesis of two classes of antibody, gammaM and gammaG or gammaM and gammaA, by identical cells. Amplification of the antibody response to pneumococcal polysaccharide type III. J Exp Med (1979) 1.06
Stimulation of macrophages by cord factor and by heat-killed and living BCG. Infect Immun (1977) 1.05
Lack of age-associated immune dysfunction in mucosal-associated lymph nodes. J Immunol (1981) 1.04
Phase-I study of intravenous modified lipid A. Cancer Immunol Immunother (1984) 1.03
The effects of age on the immune response to type III pneumococcal polysaccharide (SIII) and bacterial lipopolysaccharide (LPS) in BALB/c, SJL/J, and C3H mice. J Immunol (1976) 1.03
The mucosal immune system in health and disease, with an emphasis on parasitic infection. Bull World Health Organ (1984) 1.01
Formation of antibody in the newborn mouse: study of T-cell-independent antibody response. J Infect Dis (1977) 1.00
Effect of monophosphoryl lipid A on the in vitro function of peritoneal leukocytes from uremic patients on continuous ambulatory peritoneal dialysis. J Clin Microbiol (1989) 1.00
The adjuvant properties of a nontoxic monophosphoryl lipid A in hyporesponsive and aging mice. J Biol Response Mod (1987) 0.95
Pneumococcal vaccine: an emerging consensus. Ann Intern Med (1988) 0.92
Immune response of elderly adults to pneumococcus: variation by age, sex, and functional impairment. J Gerontol (1987) 0.90
The mucosal immunologic network. Ann Allergy (1984) 0.87
Primary antibody responses to thymus-independent antigens in the lungs and hilar lymph nodes of mice. Infect Immun (1990) 0.85
Local immune responses. Br Med Bull (1985) 0.82
Antibody responses to thymic independent antigens in the peripheral and mesenteric lymph nodes of mice. Reg Immunol (1990) 0.78
Lyb-7, a new B cell alloantigen controlled by genes linked to the IgCH locus. J Immunol (1979) 1.43
Tritium (3H) radiolabeling of protein A and antibody to high specific activity: application to cell surface antigen radioimmunoassays. J Immunol Methods (1979) 1.21
Role of a nonimmunoglobulin cell surface determinant in the activation of B lymphocytes by thymus-independent antigens. J Exp Med (1979) 1.19
Induction of B lymphocyte proliferation by monoclonal anti-Lyb 2 antibody. J Immunol (1983) 1.11
Analysis of B cell activation requirements with TNP-conjugated polyacrylamide beads. J Immunol (1979) 1.10
Differential responses of B cells from the spleen and lymph node to TNP-Ficoll. J Immunol (1988) 1.07
Activation of B lymphocytes by monovalent anti-Lyb-2 antibodies. J Exp Med (1984) 1.04
Thymus-independent antigens: complexity of B-lymphocyte activation revealed. Immunol Today (1982) 1.04
Lyb antigens and their role in B lymphocyte activation. Immunol Rev (1982) 0.99
Lyb-8.2: A new B cell antigen defined and characterized with a monoclonal antibody. Immunogenetics (1982) 0.90
Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in renal transplant recipients with gastrointestinal tract disorders. Transplant Proc (2008) 0.88
A mouse monoclonal antibody specific for an allotypic determinant of the Igha allele of murine IgM: genetic and functional analysis of Igh-6a epitopes using anti-IgM monoclonal antibodies. Hybridoma (1991) 0.87
Enhancement by monoclonal anti-Lyb-2 antibody of antigen-specific B lymphocyte expansion stimulated by TNP-Ficoll and T lymphocyte-derived factors. J Immunol (1986) 0.85
Primary antibody responses to thymus-independent antigens in the lungs and hilar lymph nodes of mice. Infect Immun (1990) 0.85
Macrophages but not B cells from aged mice are defective in stimulating autoreactive T cells in vitro. Mech Ageing Dev (1990) 0.83
The influence of avidity on signaling murine B lymphocytes with monoclonal anti-IgM antibodies. Effects of B cell proliferation versus growth inhibition (tolerance) of an immature B cell lymphoma. J Immunol (1991) 0.82
The action of an Lyb2.1-specific monoclonal antibody in soluble or immobilized form on resting and activated B cells. Curr Top Microbiol Immunol (1984) 0.81
Priming of peripheral lymph node B cells with TNP-Ficoll: role of lymphokines in B cell differentiation. Cell Immunol (1992) 0.80
Isolation and immunological characterization of a group of new B lymphomas from CBA mice. Clin Immunol Immunopathol (1989) 0.79
Reversal of age-associated decline in immune response to Pnu-imune vaccine by supplementation with the steroid hormone dehydroepiandrosterone. Infect Immun (1993) 0.79
A specific defect in the proliferative capacity of B cells from old mice stimulated with autoreactive T cells. Cell Immunol (1989) 0.78
Antibody responses to thymic independent antigens in the peripheral and mesenteric lymph nodes of mice. Reg Immunol (1990) 0.78
Cyclosporin A blocks surface IgM-mediated growth inhibition in an immature B lymphoma, BKS-2. Eur J Immunol (1991) 0.77
The synergistic effects of anti-IgM and monoclonal anti-Ia antibodies in induction of murine B lymphocyte activation. J Mol Cell Immunol (1988) 0.77
Physiology of murine B lymphocytes. I. Life-spans of anti-mu and haptenated Ficoll (thymus-independent antigen)-reactive B cells. Eur J Immunol (1988) 0.76
Reaction of brain hexokinase with tetranitromethane: oxidation of essential thiol groups. Arch Biochem Biophys (1977) 0.76
Physiology of murine B lymphocytes. II. Life-spans of mitogen and thymus-independent antigen (type 2) reactive B lymphocytes from aged mice. Mech Ageing Dev (1991) 0.75
Preliminary evidence for a new non-H-2 locus that codes for lymphocyte-activating determinants distinct from Mls. Transplant Proc (1979) 0.75
Effects of cigarette smoke on the antibody responses to thymic independent antigens from different lymphoid tissues of mice. Arch Toxicol (1992) 0.75
B lymphocyte development, heterogeneity, and function. Arthritis Rheum (1978) 0.75
Inactivation of brain hexokinase by an adenosine 5'-triphosphate analog. Arch Biochem Biophys (1977) 0.75
Impaired autoreactive T cell-induced T cell-T cell interaction in aged mice. Cell Immunol (1988) 0.75
Three years of cadaveric renal transplantation. J Assoc Physicians India (2001) 0.75
Imipramine disposition in alcoholics. J Clin Psychopharmacol (1982) 0.75
Early events in B-cell activation: anti-Lyb2, but not BSF-1, induces a phosphatidylinositol response in murine B cells. Cell Immunol (1987) 0.75